Regeneron Pharmaceuticals shares owned by Prentiss Smith & Co
Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Prentiss Smith & Co
from 13F filings
Historical chart of Prentiss Smith & Co investment in Regeneron Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Regeneron Pharmaceuticals held by Prentiss Smith & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Regeneron Pharmaceuticals by Prentiss Smith & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $3.4M | 3.5k | 962.49 |
| 2023-12-31 | $3.2M | 3.7k | 878.29 |
| 2023-09-30 | $4.5M | 5.4k | 822.96 |
| 2023-06-30 | $4.0M | 5.6k | 718.54 |
| 2023-03-31 | $4.6M | 5.6k | 821.67 |
| 2022-12-31 | $4.1M | 5.7k | 721.49 |
| 2022-09-30 | $4.1M | 5.9k | 688.93 |
| 2022-06-30 | $3.6M | 6.0k | 591.20 |
| 2022-03-31 | $4.3M | 6.2k | 698.35 |
| 2021-12-31 | $7.5M | 12k | 631.50 |
| 2021-09-30 | $6.9M | 12k | 605.16 |
| 2021-06-30 | $6.4M | 12k | 558.51 |
| 2021-03-31 | $5.6M | 12k | 473.18 |
| 2020-12-31 | $3.3M | 6.8k | 483.16 |
| 2020-09-30 | $4.3M | 7.7k | 559.75 |
| 2020-06-30 | $4.9M | 7.9k | 623.70 |
| 2020-03-31 | $3.8M | 7.9k | 488.31 |
| 2019-12-31 | $6.0M | 16k | 375.47 |
| 2019-09-30 | $4.6M | 17k | 277.41 |
| 2019-06-30 | $5.1M | 16k | 313.02 |
| 2018-12-31 | $2.6M | 7.0k | 373.47 |
| 2018-09-30 | $2.8M | 6.9k | 403.99 |
| 2018-06-30 | $3.9M | 11k | 345.00 |
| 2018-03-31 | $6.8M | 20k | 344.35 |
| 2017-12-31 | $4.8M | 13k | 375.95 |
| 2017-09-30 | $416k | 931 | 446.83 |
| 2017-03-31 | $291k | 751 | 387.48 |
| 2016-12-31 | $242k | 660 | 366.67 |
| 2016-09-30 | $70k | 175 | 400.00 |
| 2016-06-30 | $61k | 175 | 348.57 |
| 2016-03-31 | $63k | 175 | 360.00 |
| 2015-12-31 | $95k | 175 | 542.86 |
| 2015-09-30 | $81k | 175 | 462.86 |
| 2015-06-30 | $89k | 175 | 508.57 |
| 2015-03-31 | $79k | 175 | 451.43 |
| 2014-12-31 | $72k | 175 | 411.43 |